Clinical trials
Colitis, Ulcerative trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 9 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 10 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 11 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
| Terminated | 23 |
| Active, not recruiting | 19 |
| Recruiting | 12 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 15 |
| Pfizer | 9 |
| AbbVie | 8 |
| Takeda | 8 |
| Bristol-Myers Squibb | 7 |
| Shire | 7 |
| Gilead Sciences | 5 |
| Amgen | 4 |
| Arena Pharmaceuticals | 4 |
| Eli Lilly and Company | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 128 |
| Inflammatory Bowel Diseases | 25 |
| Crohn Disease | 15 |
| Colitis | 5 |
| Gastroenteritis | 2 |
| Gastrointestinal Diseases | 2 |
| Arthritis, Juvenile | 1 |
| Arthritis, Psoriatic | 1 |
| Autoimmune Diseases | 1 |
| Colitis, Microscopic | 1 |
Trials
Showing 76 to 100 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.